Literature DB >> 28626515

Inhibitors of DNA Gyrase-GyrB Subunit and/or Topoisomerase IV-ParE Subunit May Treat Infectious Diseases Caused by Antibiotic-Resistant Bacteria.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2017        PMID： 28626515      PMCID： PMC5467192          DOI： 10.1021/acsmedchemlett.7b00207

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase.

Authors:  David E Ehmann; Sushmita D Lahiri
Journal:  Curr Opin Pharmacol       Date:  2014-09-29       Impact factor: 5.547

2.  Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.

Authors:  Michael F Mesleh; Jason B Cross; Jing Zhang; Jan Kahmann; Ole A Andersen; John Barker; Robert K Cheng; Brunella Felicetti; Michael Wood; Andrea T Hadfield; Christoph Scheich; Terence I Moy; Qingyi Yang; Joseph Shotwell; Kien Nguyen; Blaise Lippa; Roland Dolle; M Dominic Ryan
Journal:  Bioorg Med Chem Lett       Date:  2016-01-06       Impact factor: 2.823

Review 3.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 4.  Dual targeting DNA gyrase B (GyrB) and topoisomerse IV (ParE) inhibitors: A review.

Authors:  Mohammed Afzal Azam; Janarthanan Thathan; Selvaraj Jubie
Journal:  Bioorg Chem       Date:  2015-07-23       Impact factor: 5.275
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.